Ainara Mira‐Iglesias

Author

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana ORCID

Also Known As

A Mira-Iglesias, A. Mira-Iglesias, Ainara Mira-Iglesias, Ainara Mira‐Iglesias, Arantxa Urchueguía-Fornes, M. Lourdes Guerrero, Mira-Iglesias, A, Mira-Iglesias, Ainara

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana Instituto de Salud Carlos III Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública Hospital General Universitari de Castelló Hospital Universitario Doctor Peset

About

Ainara Mira‐Iglesias is an author at Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana specializing in preventive medicine, infection control, and precision vaccinology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	17
2	Public Health	1	1	17
3	Epidemiology	1	1	17
4	Clinical Epidemiology	1	1	17
5	Precision Vaccinology	1	1	17

Ainara Mira‐Iglesias

Publications

551

Citations

H-Index

Page 1

	Year	Citations
Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024 Mónica López‐Lacort, Cintia Muñoz-Quiles, Ainara Mira‐Iglesias, Eurosurveillance	2024	158
Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015 Joan Puig‐Barberà, Ainara Mira‐Iglesias, Miguel Tortajada‐Girbés, Vaccine	2017	63
Epidemiology of Hospital Admissions with Influenza during the 2013/2014 Northern Hemisphere Influenza Season: Results from the Global Influenza Hospital Surveillance Network Joan Puig‐Barberà, Angels Natividad-Sancho, Anna Sominina, PLoS ONE	2016	52
Role of age and birth month in infants hospitalized with RSV‐confirmed disease in the Valencia Region, Spain Ainara Mira‐Iglesias, Clarisse Demont, F. Xavier López‐Labrador, Influenza and Other Respiratory Viruses	2021	29
Effectiveness of influenza vaccination programme in preventing hospital admissions, Valencia, 2014/15 early results Joan Puig‐Barberà, Ainara Mira‐Iglesias, Miguel Tortajada‐Girbés, Eurosurveillance	2015	27
Influenza epidemiology and influenza vaccine effectiveness during the 2015–2016 season: results from the Global Influenza Hospital Surveillance Network Joan Puig‐Barberà, Ainara Mira‐Iglesias, Benjamin J. Cowling, BMC Infectious Diseases	2019	24
Background rates of Adverse Events of Special Interest for monitoring COVID-19 vaccines Corinne Willame, Caitlin Dodd, Rosa Gini, Zenodo (CERN European Organization for Nuclear Research)	2021	24
Nirsevimab Effectiveness Against Severe Respiratory Syncytial Virus Infection in the Primary Care Setting Mónica López‐Lacort, Cintia Muñoz-Quiles, Ainara Mira‐Iglesias, PEDIATRICS	2024	23
Predictors of influenza severity among hospitalized adults with laboratory confirmed influenza: Analysis of nine influenza seasons from the Valencia region, Spain Nieves Derqui, Joshua Nealon, Ainara Mira‐Iglesias, Influenza and Other Respiratory Viruses	2022	20
Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season Joan Puig‐Barberà, Beatriz Guglieri-López, Miguel Tortajada‐Girbés, Vaccine	2017	18

Page 1